After winning the 2020 Swiss Healthcare Startup Competition in April, Neurosoft Bioelectronics (LSBI spin-off) was awarded a grant by Catalyze4Life (C4L).
Catalyze4Life (C4L) is an initiative from the EPFL’s School of Life Sciences to promote and support innovative technologies in the life sciences field. From its recent calls for projects, seven promising projects were selected as semi-finalists, and three of them were awarded funding.
Among them, Neurosoft Bioelectronics (a spin-off from LSBI led by Nicolas Vachicouras, Ludovic Serex and Florian Fallegger), was awarded a grant to further develop minimally invasive soft electrode arrays which seamlessly conform to the surface of human organs, such as the brain. These electrodes developed at the LSBI, allow recording and stimulation of the nervous system for the treatment of neurological disorders and could be used to map organ surfaces, as in the case of epicardial mapping.
This funding was obtained by Neurosoft Bioelectronics after having recently won the 2020 Swiss Healthcare StartupCompetition in April (a competition led by Swissnex San Francisco and supported by Migros to expose Swiss technologies to the funding ecosystem of the San Francisco Bay Area), and being selected as one of the top ten Venture Leaders Life Sciences 2020 team, an initiative by VentureLab to promote Swiss high tech towards the Boston investment hub. All three programs are accompanied by coaching, market exposure, feedback from investors and experts, and hands-on business development.
Additionally, the two other recipients of the C4L funding are Frank Bonnet (Biorobotics Laboratory and Bionomous), for the development of a zebrafish egg sorting device, and Luca Randazzo (Biorobotics Laboratory and EmovoCare) for the development of YAGO, a hand exoskeleton that can be used for assistive and rehabilitation support, a project that started at the Defitech Chair in Brain-Machine Interface (José Millan) at CNP.
News
Partner